Prostate specific membrane antigen (PSMA) [7–9] and the folate receptor [10–13] are well characterized and most attractive cancer biomarkers present in primary and metastatic stages of prostate and ovarian cancers, respectively. Here, FOLH1 is linked to ovarian carcinoma.